Ethylene oxide, a widely-used chemical intermediate and fumigant, is carcinogenic to animals and is """"""""probably carcinogenic to humans,"""""""" according to the IARC. The initiating event is presumed to be DNA damage, and repair is probably a major cellular defense. Thus, ethylene oxide is an excellent model for the study of environmental exposure. In this project, we will: 1) Determine the nature of the DNA modifications which are caused by ethylene oxide; 2) Determine what bacterial and mammalian enzymes repair these lesions; and 3) Develop an assay for DNA damage which could be used to monitor the risk of ethylene oxide exposure. The chemical nature of the nucleoside modifications produced by ethlylene oxide will be determined by incubating deoxyribonucleosides with ethylene oxide and separating the reaction mixtures by HPLC. Structures of the modified deoxynucleosides will be determined by comparison with known standards already available in this laboratory, and by ultraviolet, NMR, and mass spectrometry. DNA will be reacted with ethylene oxide in buffered aqueous solution at 37 degree C and digested enzymatically. Digests will be separated by HPLC, and modified peaks will be identified in comparison with known markers. To investigate the repair of ethylene oxide-induced DNA lesions, nick-translated DNA's will be prepared from 14C-deoxynucleoside triphosphates, and modified with ethylene oxide. Removal or repair of these modified bases will be studied with specific, bacterial repair enzymes and calf thymus extracts. A sensitive method will be developed for determining the extent of modification in lymphocyte DNA. In collaboration with other laboratories, monoclonal antibodies will be developed to modified nucleosides; at the same time, we will develop a GC/MS assay as an alternate analytical method. Ultimately, it will be possible to standardize these methods to monitor human exposure because the nitrosoureas currently used in cancer chemotherapy produce many of the same DNA modifications that ethylene oxide presumably causes in exposed personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047103-03
Application #
3190585
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1988-04-01
Project End
1992-03-31
Budget Start
1990-04-01
Budget End
1992-03-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Matijasevic, Z; Boosalis, M; Mackay, W et al. (1993) Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc Natl Acad Sci U S A 90:11855-9
Niu, T; Yu, D; Kirk, M C et al. (1993) Synthesis of the prototype DNA-protein cross-link, 1-(guan-1-yl)-2-(cysteine-S-yl)ethane, and its role in the reactions of the haloethylnitrosoureas. Carcinogenesis 14:195-8
Ludlum, D B; Habraken, Y; Carter, C A et al. (1992) The formation and enzymatic repair of DNA modifications caused by the haloethylnitrosoureas and related compounds. Nucleic Acids Symp Ser :25-6
Matijasevic, Z; Sekiguchi, M; Ludlum, D B (1992) Release of N2,3-ethenoguanine from chloroacetaldehyde-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Proc Natl Acad Sci U S A 89:9331-4
Habraken, Y; Carter, C A; Kirk, M C et al. (1991) Release of 7-alkylguanines from N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase II. Cancer Res 51:499-503
Habraken, Y; Carter, C A; Sekiguchi, M et al. (1991) Release of N2,3-ethanoguanine from haloethylnitrosourea-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Carcinogenesis 12:1971-3
Young, T L; Habraken, Y; Ludlum, D B et al. (1990) Development of monoclonal antibodies recognizing 7-(2-hydroxyethyl)guanine and imidazole ring-opened 7-(2-hydroxyethyl)guanine. Carcinogenesis 11:1685-9
Carter, C A; Habraken, Y; Ludlum, D B (1988) Release of 7-alkylguanines from haloethylnitrosourea-treated DNA by E. coli 3-methyladenine-DNA glycosylase II. Biochem Biophys Res Commun 155:1261-5